Ritter Pharma (RTTR) and Qualigen Announce All-Stock Merger Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Ritter Pharma (RTTR) and Qualigen Announce All-Stock Merger Agreement

Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement

January 21, 2020 9:15 AM EST

Transaction to Create a Nasdaq-listed Biotechnology Company Focused on Advancing Qualigens Cancer and Infectious Disease Therapeutic Development Programs

LOS ANGELES, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (Ritter Pharmaceuticals or the Company), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, reported that it has entered into a definitive reverse merger agreement with Qualigen, Inc. (Qualigen), a privately-held company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship... More